A 52-year-old male patient, who had been a butcher for a long time, was admitted to the Dermatological and Venereal Diseases Outpatient Clinic due to a lesion that had first occurred on the fingers of his right hand about 25-30 years ago and had gradually extended to its current shape over time. In the investigation of the patient' s medical history, it was found that he had not benefited from the previous therapies with topical agents. Dermatological examination revealed a squamous hyperkeratotic, well-delimited, approximately 15x20-cm plaque lesion with verrucous appearance and flesh-coloured on the volar and dorsal surfaces of the right hand (Figure 1a, b) .
A 52-year-old male patient, who had been a butcher for a long time, was admitted to the Dermatological and Venereal Diseases Outpatient Clinic due to a lesion that had first occurred on the fingers of his right hand about 25-30 years ago and had gradually extended to its current shape over time. In the investigation of the patient' s medical history, it was found that he had not benefited from the previous therapies with topical agents. Dermatological examination revealed a squamous hyperkeratotic, well-delimited, approximately 15x20-cm plaque lesion with verrucous appearance and flesh-coloured on the volar and dorsal surfaces of the right hand (Figure 1a , b).
Skin biopsy was performed for the diagnosis of the patient whose routine blood test and chest radiography results were found to be within normal intervals. During histopathological examination of the lesion, hyperkeratosis, acanthosis, and papillomatosis in the epidermis, mononuclear inflammatory cell infiltrate just below the epithelium, and granulomatous inflammation and giant cells with necrosis in the middle dermis were observed ( Figure 2 
Correct answer b: Tuberculosis verrucosa cutis
Tuberculosis verrucosa cutis (TBVC) is a paucibacillary form of cutaneous tuberculosis caused by exogenous re-infection in previously sensitised individuals. It is also known as warty tuberculosis, anatomist's wart, butcher's wart, verruca necrogenica, and lupus verrucosus. It is contaminated by the inoculation of bacilli into the skin in the individuals with moderate or high immunity. Inoculation occurs at the sites of minor wounds or abrasions, and rarely in the patient's sputum. Most of the time, the responsible agent is mycobacterium tuberculosis hominis and less frequently, mycobacterium bovis or mycobacterium avium. TBVC is a rare form of cutaneous tuberculosis in western countries, which can be quite common in the continent of Asia. In Europe, the affected parts of the body are mostly the hands, but in Eastern countries, the knees, ankles and buttocks are more often affected, which are generally areas that are exposed to trauma (1, 2) . From a clinical aspect, it first presents as a small indurated nodule and then gradually extends, producing an irregular reddish-brown warty plaque. In some areas, healing is observed with an atrophic pale scar. Its differential diagnosis must clinically be made by deep fungus infections such as blastomycosis and chromomycosis, lichen simplex chronicus, and hypertrophic lichen planus (3, 4) .
Its histopathological features are characterised by acanthotic papillomatosis with marked hyperkeratosis and granulomatous infiltrate caseous necrosis, consisting of neutrophils and lymphocytes in the deeper dermis (5, 6) . In the biopsy sample taken from our case, hyperkeratosis, acanthosis, and papillomatosis in the epidermis, mononuclear inflammatory cell infiltrate just below the epithelium, and granulomatous inflammation and Langhans-type giant cells with caseous necrosis in the middle dermis were observed.
In the literature, there are many case studies demonstrating that polymerase chain reaction (PCR) is useless for determining mycobacterium tuberculosis from cutaneous tuberculosis. PCR is often negative in the paucibacillary form of cutaneous tuberculosis. For cases with a strong suspicion of tuberculosis, despite negative laboratory test results, anti-tuberculous therapy can be initiated. After this standard anti-tuberculous treatment, healing is expected to occur within 4-5 months (7, 8) .
In our case, after the clinical and histopathological diagnosis of a patient with TBVC, quadruple anti-tuberculous therapy (isoniazide 300 mg/day, rifampicin 600 mg/day, pyrazinamide 1500 mg/day, ethambutol 1500 mg/day) was applied for the first two months and, subsequently, the patient was exposed to binary maintenance therapy for the following four months (isoniazide 300 mg/day, rifampicin 600 mg/ day). At the end of treatment, the lesion in the right hand regressed completely leaving post-inflammatory hypopigmentation ( Figure 3 ).
The progression of TBVC is slow. If can become chronic if it is not treated. There are only a few cases where lesions are present for more than 20 years. In our case, the patient had experienced the lesions for about 25-30 years, and responded to the standard anti-tuberculous treatment within a short period of 2 months (Figure 3a, b) .
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